Infection is the leading cause of death in LR-MDS patients, responsible for 24.6% of deaths within a year of diagnosis. Key risk factors for infection include intermediate or higher IPSS-R risk, ...
After a brief introduction, medical experts discuss advances in MDS classification and molecular understanding. Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the ...
If you have myelodysplastic syndromes (MDS) and are feeling healthy, your doctor will likely take a “watch and wait” approach. You may feel anxiety and fear toward this approach, but there are ways to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results